thefederalregister.org
Federal Register Research Archive
Latest RSS
Changes RSS
Search
Status
Home
/
90 FR 59532
Citation
90 FR 59532
Canonical document for this Federal Register citation.
Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph)
Friday, December 19, 2025
90 FR 59532